Skip to main content

Amyotrophic Lateral Sclerosis: Accelerating Treatments and Improving Quality of Life

Completed

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, invariably fatal neurological disease. Individuals affected by ALS include those living with ALS, their caregivers, presymptomatic individuals at risk for developing ALS, and others. Currently no treatments stop or reverse the disease, although various FDA-approved formulations may extend life by several months. This committee will identify and recommend key actions for the public, private, and nonprofit sectors to undertake to make ALS a livable disease within a decade.

Events

Meetings
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.